ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch
ActiveIDE / TVA
CHE-209.784.395 MWST
Numéro du registre du commerce
CH-440-1038220-9
Siège
Kreuzlingen
But
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.
Management
AI-generated contentRejoignez Notre Programme Bêta
Nous développons activement la plateforme. Inscrivez-vous pour un accès bêta et bénéficiez d'un accès exclusif anticipé aux nouvelles fonctionnalités.
Publications
22.05.2024
25.03.2022
Frequently Asked Questions
What is the legal status of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is Active in the Swiss Commercial Register.
What is the UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
The UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is CHE-209.784.395.
Where is ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch located?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is located in Kreuzlingen with its registered address at Eichhornweg 1, 8280 Kreuzlingen.
What is the legal form of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is registered as a Entreprise individuelle (EI) in Switzerland.
What is the purpose of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.